logo
Velociraptor's new cousin is a raptor unlike any seen before

Velociraptor's new cousin is a raptor unlike any seen before

Yahoo4 days ago
Sometime before 2010, in the red sands of Mongolia's Gobi Desert brimming with fossils, poachers excavated and stole the exquisite skeleton of a carnivorous dinosaur.
They smuggled the fossil out of the country and onto the black market. It passed through private collections in Japan and England and was eventually acquired by the French fossil company Eldonia. In 2016, one of the fossil's owners had the dinosaur's skull and four vertebrae CT-scanned at a Belgian museum, but sometime later the head and neck went missing. Their whereabouts remain unknown to scientists. Negotiations between the fossil company, paleontologists, and government officials led to the return of the dinosaur's body to Mongolia, where it could be cared for and studied, a raptor unlike any seen before.
Now, this headless, extra-sharp relative of Velociraptor finally has a name: Shri rapax.
The roughly six-foot-long, turkey-sized dinosaur wandered a prehistoric desert more than 71 million years ago. Like Velociraptor, which was also found in Mongolia, Shri is a dromaeosaur. This predatory dinosaur group includes Deinonychus, Utahraptor, and other feathery carnivores with large, hyperextendable claws on their second toes.
"I was so surprised to find such an unexpected dromaeosaur in the same geological setting of the iconic Velociraptor," says Andrea Cau an independent paleontologist from Italy.
Cau and his colleagues published a paper on July 13 in the journal Historical Biology describing the new species. The discovery is part of a growing number of raptor-like dinosaurs found in Mongolia, revealing an unexpected diversity of species and body types in this group, such as the goose-necked and slender Halszkaraptor escuilliei and Natovenator polydontus.
Stronger bite, bigger claws
Despite its close relationship to the Hollywood-famous Velociraptor, Shri was a very different dinosaur. A cast of its skull, which was made based off the 2016 CT-scan as the actual fossil skull is still missing, indicates Shri had a deeper and shorter snout. The finding hints that this raptor had a stronger bite than its relative.
"Other differences, such as a relatively short snout, proportionally long neck, and short tail indicate that these two relatives had different ecological preferences," says Tsogtbaatar Chinzorig, a paleontologist at the North Carolina Museum of Natural Sciences and a coauthor of the study.
Its arm bones are more robust and stockier, tipped with large, curved claws. It also had stout hands that imply a strong grip. Precisely how Shri used its arms and claws is unclear, though the researchers suggest it may have grappled with and grasped other dinosaurs like the horned herbivore Protoceratops. Bitten Protoceratops bones and a famous fossil of Velociraptor and Protoceratops locked in fossil combat, called the "Fighting Dinosaurs," hint that the pig-like horned dinosaurs were prey for dromaeosaurs like Shri.
Michael Pittman, a paleontologist at the Chinese University of Hong Kong who was not involved in the research, says the authors' hypothesis is reasonable, and that biomechanical studies of the dinosaur's arms can potentially test the idea. He also calls the specimen, "beautiful and well-preserved."
The likelihood Shri rapax and Velociraptor lived alongside each other points to a phenomenon called "niche partitioning." Closely related species can sometimes share the same landscape when they have different dietary preferences and behaviors, like how the island of Madagascar hosts many different lemur species that live in different habitats and eat different foods.
Evolving different specializations allow related animals to divide habitats in different ways, boosting biodiversity. In the case of the dinosaurs, the anatomical differences between Shri and Velociraptor indicate that the carnivores were likely also part of such an ecological interplay.
Returning Shri rapax home
Because Shri's skeleton was poached and sold with no geological information, paleontologists are unsure exactly from where the dinosaur was excavated, beyond its clear origin from Mongolia's Djadokhta Formation. The fact that scientists have been able to study, describe, and begin to understand Shri rapax is a victory for paleontology and an effort to push back against black market fossil dealings."This case highlights yet another instance of fossil poaching," Chinzorig says, "part of a long-standing pattern of illegal smuggling of fossils from the Mongolian Gobi over the decades."
It's essential that such fossils are returned, Chinzorig says, both to build scientific knowledge about the prehistoric past and to respect Mongolia's fossil heritage. If the smuggled fossil had remained in private hands, scientists would not know this new dinosaur, its relationships, or anything about the role it played in its prehistoric ecosystem.
"Scientific value aside," Cau adds, "I am really happy to give some help in returning these dinosaurs home." And by introducing Shri rapax to the world, the paleontologists may, with luck, help return its missing head home.
Solve the daily Crossword
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Common sweetener could hold untapped potential to fight aggressive cancer, study finds
Common sweetener could hold untapped potential to fight aggressive cancer, study finds

Yahoo

time3 hours ago

  • Yahoo

Common sweetener could hold untapped potential to fight aggressive cancer, study finds

A household sweetener could hold the potential to create an anti-cancer treatment. New research from Hiroshima University in Japan revealed that stevia leaf extract could help fight pancreatic cancer cells. The leaves of the stevia plant (Stevia rebaudiana) are used to make stevia extract, a naturally sweet substance commonly used as a sugar substitute. Two Cancer Drugs Show Promise In Reversing Alzheimer's Devastating Effects The study, published in the International Journal of Molecular Sciences, investigated the anti-cancer properties of stevia leaf extract when it is fermented with a certain strain of bacteria. In laboratory research, the fermented extract exhibited "significantly enhanced antioxidant activity and cytotoxicity" against pancreatic cancer cells, the researchers revealed. Read On The Fox News App This led them to believe that this substance could serve as a "promising candidate for pancreatic cancer treatment." Paul E. Oberstein, M.D., medical oncologist and assistant director of the Pancreatic Cancer Center at NYU Langone Perlmutter Cancer Center, shared his thoughts in an interview with Fox News Digital. Ancient 'Pharaoh's Curse' Fungus Shows Promise In Killing Cancer Cells "This is an interesting study because it evaluated something derived from a natural plant (stevia) and showed that it may have utility in stopping cancer cells from growing in the laboratory," he said. "As the authors point out, the actual stevia plant does not seem to have any benefit for stopping cancer, so they had to use a chemical process to change the plant and make it stronger with a fermentation process." Oberstein recommended approaching this with caution, as it is unknown whether altering the plant will lead to side effects or toxicity. The study was not performed on humans, so there is "still a lot that's unknown about whether this will help patients," the oncologist added. As stevia extract alone does not have an impact on cancer cells, Oberstein said these findings most likely will not lead to any immediate changes in treatment plans. "The study suggests that if the stevia can be changed in the lab, it may have an impact, so hopefully they will further test this and determine whether this effect happens when tested in people and if it doesn't cause new side effects," he added. "I hope the researchers keep testing this in various formats and in people." Dr. Kristen Arnold, a surgical oncologist and pancreatic cancer specialist at the Orlando Health Cancer Institute, reacted to these study findings in a separate interview with Fox News Digital. "Pancreatic cancer is a very aggressive malignancy," she said. "And we know that even with the most aggressive of therapies, unfortunately, our outcomes are not good." "As a pancreatic cancer community, we spend a lot of time and there's a lot of ongoing effort into trying to find better modalities to treat this disease." Although more research is needed to confirm these preliminary findings, Arnold said she is encouraged by the study. Click Here To Sign Up For Our Health Newsletter "I think the data's very early to know if it's ultimately going to be a game-changer, but it's very exciting to know that we're finding some positive pre-clinical data," she said. "This is the process of how we discover new treatments – some of which turn out to be absolute game-changers and make dramatic changes in the lives of our patients." "Not all of it pans out, but it's a process of discovery," Arnold added. For those with pancreatic cancer, Arnold recommends seeking out appropriate clinical trial opportunities as new science develops. For more Health articles, visit "The clinical trials are ultimately what determine how we treat patients on a day-to-day basis," she added. Fox News Digital reached out to the study authors for article source: Common sweetener could hold untapped potential to fight aggressive cancer, study finds Solve the daily Crossword

China is betting on a real-world use of AI to challenge U.S. control
China is betting on a real-world use of AI to challenge U.S. control

Yahoo

time7 hours ago

  • Yahoo

China is betting on a real-world use of AI to challenge U.S. control

SHANGHAI - As the United States and China vie for control over the future of artificial intelligence, Beijing has embarked on an all-out drive to transform the technology from a remote concept to a newfangled reality, with applications on factory floors and in hospitals and government offices. China does not have access to the most advanced chips required to power cutting-edge models due to restrictions from Washington and is still largely playing catch-up with Silicon Valley giants like OpenAI. But experts say Beijing is pursuing an alternative playbook in an attempt to bridge the gap: aggressively pushing for the adoption of AI across the government and private sector. (The Washington Post has a content partnership with OpenAI.) Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. 'In China, there's definitely stronger government support for applications and a clear mandate from the central government to diffuse the technology through society,' said Scott Singer, an expert on China's AI sector at the Carnegie Endowment for International Peace. By contrast, the U.S. has been more focused on developing the most advanced AI models while 'the application layer has been totally ignored,' he said. China's push was on full display in Shanghai at its World Artificial Intelligence Conference, which ran until Tuesday. Themed 'Global Solidarity in the AI Era,' the expo is one part of Beijing's bid to establish itself as a responsible AI leader for the international community. This pitch was bolstered by the presence of international heavyweights like Eric Schmidt, former CEO of Google, and Geoffrey Hinton, a renowned AI researcher often called the 'Godfather of AI.' During the event, Beijing announced an international organization for AI regulation and a 13-point action plan aimed at fostering global cooperation to ensure the technology's beneficial and responsible development. 'China attaches great importance to global AI governance,' Li Qiang, China's premier, said at the opening ceremony on Saturday. It 'is willing to share its AI development experience and technological products to help countries around the world - especially those in the Global South,' he said, according to an official readout. Just last week, President Donald Trump announced a competing plan in a bid to boost American AI competitiveness by reducing regulation and promoting global exports of U.S. AI technology. Washington has moved in recent years to restrict China's access to chips necessary for AI development, in part due to concerns about potential military applications of such models and degrading U.S. tech leadership. The Trump administration's approach to chip policy, however, has been mixed. Earlier this month, the White House reversed a previous ban on specific AI chips made by U.S. tech giant Nvidia being exported to China. This shift occurred amid trade negotiations between the world's two largest economies, which have been locked in an escalating tariff and export control war since Trump returned to the Oval Office earlier this year. There was nothing but excitement about AI in the vast expo center in Shanghai's skyscraper-rich Pudong district, where crowds entered gates controlled by facial recognition. Inside, thousands of attendees listened to panels stacked with Chinese government officials, entrepreneurs and international researchers, or watched demonstrations on using AI to create video games, control robotic movements and respond in real time to conversations via smartglasses. Chinese giants like Huawei and Alibaba and newer Chinese tech darlings like Unitree Robotics were there. DeepSeek was not present, but its name was spoken everywhere. The Hangzhou-based upstart has been at the forefront of Beijing's attempt to push the government use of AI since it released a chatbot model in January, prompting a global craze and driving home China's rapid AI advances. DeepSeek has been put to work over the last six months on a wide variety of government tasks. Procurement documents show military hospitals in Shaanxi and Guangxi provinces specifically requesting DeepSeek to build online consultation and health record systems. Local government websites describe state organs using DeepSeek for things like diverting calls from the public and streamlining police work. DeepSeek helps 'quickly discover case clues and predict crime trends,' which 'greatly improves the accuracy and timeliness of crime fighting,' a city government in China's Inner Mongolia region explained in a February social media post. Anti-corruption investigations - long a priority for Chinese leader Xi Jinping - are another frequent DeepSeek application, in which models are deployed to comb through dry spreadsheets to find suspicious irregularities. In April, China's main anti-graft agency even included a book called 'Efficiently Using DeepSeek' on its official book recommendation list. China's new AI action plan underscores this push, declaring that the 'public sector should take the lead in deploying applications' by embedding AI in education, transportation and health care. It also emphasizes a mandate to use AI 'to empower the real economy' and praises open-source models - which are more easily shared - as an egalitarian method of AI development. Alfred Wu, an expert on China's public governance at the National University of Singapore, said Beijing has disseminated a 'top-down' directive to local governments to use AI. This is motivated, Wu said, by a desire to improve China's AI prowess amid a fierce rivalry with Washington by providing models access to vast stores of government data. But not everyone is convinced that China has the winning hand, even as it attempts to push AI application nationwide. For one, China's sluggish economy will impact the AI industry's ability to grow and access funding, said Singer, who was attending the conference. Beijing has struggled to manage persistent deflation and a property crisis, which has taken a toll on the finances of many families across the country. 'So much of China's AI policy is shaped by the state of the economy. The economy has been struggling for a few years now, and applications are one way of catalyzing much-needed growth,' he said. 'The venture capital ecosystem in AI in China has gone dry.' Others point out that local governments trumpeting their usage of DeepSeek is more about signaling than real technology uptake. Shen Yang, a professor at Tsinghua University's school of artificial intelligence, said DeepSeek is not being used at scale in anti-corruption work, for example, because the cases involve sensitive information and deploying new tools in these investigations requires long and complex approval processes. He also pointed out that AI is still a developing technology with lots of kinks. 'AI hallucinations still exist,' he said, using a term for the technology's generation of false or misleading information. 'If it's wrong, who takes responsibility?' These concerns, however, felt far away in the expo's humming hallways. At one booth, Carter Hou, the co-founder of Halliday, a smartglasses company, explained how the lenses project a tiny black screen at the top of a user's field of vision. The screen can provide translation, recordings and summaries of any conversation, and even deploy 'proactive AI,' which anticipates questions based on a user's interactions and provides information preemptively. 'For example, if you ask me a difficult question that is fact related,' Hou said, wearing the trendy black frames, 'all I need to do is look at it and use that information and pretend I'm a very knowledgeable person.' Asked about the event's geopolitical backdrop, Hou said he was eager to steer clear of diplomatic third rails. 'People talk a lot about the differences between the United States and China,' he said. 'But I try to stay out of it as much as possible, because all we want to do is just to build good products for our customers. That's what we think is most important.' Kiki Lei, a Shanghai resident who started an AI video company and attended the conference on Sunday, seemed to agree with this goal. She said that Chinese AI products are easier to use than U.S. products because companies here really 'know how to create new applications' and excel at catering to, and learning from, the large pool of Chinese technology users. Robots, perhaps the most obvious application of AI in the real world, were everywhere at the conference - on model factory floors and in convenience stores retrieving soda cans, shaking disbelieving kids' hands, or just roaming the packed halls. At the booth for ModelBest, another Beijing-based AI start-up, a young student from China's prestigious Tsinghua University, who was interning at the company, demonstrated how a robot could engage with its surroundings - and charm its human interlocutors. Looking directly at the student, the robot described his nondescript clothing. 'The outfit is both stylish and elegant,' the robot continued. 'You have a confident and friendly demeanor, which makes you very attractive.' - - - Pei-Lin Wu in Taiwan contributed to this report. --- Video Embed Code Video: Robots ruled at the World Artificial Intelligence Conference in Shanghai, where China displayed its latest tech and AI innovation. Washington Post China correspondent Katrina Northrop reported from the event on July 26.(c) 2025 , The Washington Post Embed code: Related Content Pets are being abandoned, surrendered amid Trump's immigration crackdown The Post exposed this farmer's struggle. Then the USDA called. Kamala Harris will not run for California governor, opening door for 2028 run Solve the daily Crossword

Common sweetener could hold untapped potential to fight aggressive cancer, study finds
Common sweetener could hold untapped potential to fight aggressive cancer, study finds

Fox News

timea day ago

  • Fox News

Common sweetener could hold untapped potential to fight aggressive cancer, study finds

A household sweetener could hold the potential to create an anti-cancer treatment. New research from Hiroshima University in Japan revealed that stevia leaf extract could help fight pancreatic cancer cells. The leaves of the stevia plant (Stevia rebaudiana) are used to make stevia extract, a naturally sweet substance commonly used as a sugar substitute. The study, published in the International Journal of Molecular Sciences, investigated the anti-cancer properties of stevia leaf extract when it is fermented with a certain strain of bacteria. In laboratory research, the fermented extract exhibited "significantly enhanced antioxidant activity and cytotoxicity" against pancreatic cancer cells, the researchers revealed. This led them to believe that this substance could serve as a "promising candidate for pancreatic cancer treatment." Paul E. Oberstein, M.D., medical oncologist and assistant director of the Pancreatic Cancer Center at NYU Langone Perlmutter Cancer Center, shared his thoughts in an interview with Fox News Digital. "This is an interesting study because it evaluated something derived from a natural plant (stevia) and showed that it may have utility in stopping cancer cells from growing in the laboratory," he said. "As the authors point out, the actual stevia plant does not seem to have any benefit for stopping cancer, so they had to use a chemical process to change the plant and make it stronger with a fermentation process." "This is the process of how we discover new treatments – some of which turn out to be absolute game-changers." Oberstein recommended approaching this with caution, as it is unknown whether altering the plant will lead to side effects or toxicity. The study was not performed on humans, so there is "still a lot that's unknown about whether this will help patients," the oncologist added. As stevia extract alone does not have an impact on cancer cells, Oberstein said these findings most likely will not lead to any immediate changes in treatment plans. "The study suggests that if the stevia can be changed in the lab, it may have an impact, so hopefully they will further test this and determine whether this effect happens when tested in people and if it doesn't cause new side effects," he added. "I hope the researchers keep testing this in various formats and in people." Dr. Kristen Arnold, a surgical oncologist and pancreatic cancer specialist at the Orlando Health Cancer Institute, reacted to these study findings in a separate interview with Fox News Digital. "Pancreatic cancer is a very aggressive malignancy," she said. "And we know that even with the most aggressive of therapies, unfortunately, our outcomes are not good." "As a pancreatic cancer community, we spend a lot of time and there's a lot of ongoing effort into trying to find better modalities to treat this disease." Although more research is needed to confirm these preliminary findings, Arnold said she is encouraged by the study. "I think the data's very early to know if it's ultimately going to be a game-changer, but it's very exciting to know that we're finding some positive pre-clinical data," she said. "This is the process of how we discover new treatments – some of which turn out to be absolute game-changers and make dramatic changes in the lives of our patients." "Not all of it pans out, but it's a process of discovery," Arnold added. For those with pancreatic cancer, Arnold recommends seeking out appropriate clinical trial opportunities as new science develops. "The clinical trials are ultimately what determine how we treat patients on a day-to-day basis," she added. Fox News Digital reached out to the study authors for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store